Pierfrancesco Pavoni, an Italian sprinter who won twelve medals at international competitions, including a silver medal as well as two World Indoor bronze medals at the 1982 European Championships, suffered from frequent muscle and tendon lesions. He was one of the early beneficiaries of a first generation of oncology hyperthermia devices that served a dual purpose: healing sports injuries. Pavoni was so taken with the technology that he gave up running and instead raced to go into the business with the aim of advancing such hyperthermia medtech devices. He eventually launched his own company. The advanced hyperthermia sports medicine medtech devices it makes, called ALBA, are used by Arsenal, Chelsea, Barcelona, Juventus, InterMiland, Roma AC and other European football clubs. But Pavoni didn’t stop there. He used his experience with the medtech sports medicine devices to come full-circle, helping, as a strategic advisor, a Rome-based startup called MED-LOGIX Medical Solutions, to build a new version of ALBA dedicated to the treatment of superficial, semi-deep and deep cancerous tumors.
This article is part of The Innovator’s premium content offer and available only to The Innovator’s Radar subscribers.
If you are already a Radar subscriber click here to sign into your account.
For a free trial Radar Subscription click here.
